Protein Kinase Cβ: Linking Intestine Fibroblast Growth Factor 15 to Hepatic Extracellular Signal Regulated Kinase 1/2 Signaling in Bile Acid and Cholesterol Homeostasis  by Chiang, John Y.L.
EDITORIALProtein Kinase Cb: Linking Intestine Fibroblast Growth
Factor 15 to Hepatic Extracellular Signal Regulated Kinase
1/2 Signaling in Bile Acid and Cholesterol Homeostasisholesterol homeostasis is maintained by balancingCcholesterol input from diet and de novo synthesis
and output via conversion to bile acids in the liver and sterol
hormones in steroidogenic tissues. About 50% of choles-
terol is converted to bile acids, which facilitates biliary
secretion of another 40% of cholesterol. Thus, bile acid
synthesis and metabolism is critical for maintaining whole-
body cholesterol homeostasis. Most bile acids (w95%) in
the gastrointestinal system are reabsorbed in the ileum and
transported back to the liver to inhibit the transcription of
cholesterol 7a-hydroxylase (CYP7A1), the rate-limiting
enzyme in bile acid synthesis. The enterohepatic recircula-
tion of bile acids is an important physiologic process that
plays a critical role not only in feedback regulation of bile
acid synthesis but also in nutrient absorption and metabolic
homeostasis in the entire body. Imbalance of cholesterol and
bile acid homeostasis contributes to cholesterol gallstone
disease.
The lithogenic diet is a high-fat diet supplemented with
0.5% cholic acid and 1% cholesterol. Addition of cholic acid
facilitates cholesterol absorption in the intestine. This diet is
widely used to induce cholesterol gallstones and hypercho-
lesterolemia in rodents. In this issue of Cellular andMolecular
Gastroenterology and Hepatology, Huang and Mehta1 re-
ported that a lithogenic diet strongly induced PKCb and PKCd
mRNA and protein in hepatocytes; deﬁciency of protein ki-
nase C b (PKCb) but not PKCd promoted lithogenic diet-
induced gallstone formation. Furthermore, induction of
PKCb via lithogenic diet was reduced in Apoe/ mice but
enhanced in liver orphan receptor a–deﬁcient (Lxra/)
mice. LXRa is an oxysterol sensor that induces CYP7A1 and
bile acid synthesis but increases serum triglycerides in mice.
In PKCb/ mice, CYP7A1 mRNA expression was reduced;
low-density lipoprotein receptor, involved in uptake of
serum cholesterol to the liver, and steroid response ele-
ment–binding protein 2, involved in haptic de novo choles-
terol synthesis, were increased.
These data suggest that induction of PKCb via a litho-
genic diet may coordinately regulate hepatic cholesterol and
bile acid synthesis. Interestingly, this study showed that the
lithogenic diet enhanced the induction of ﬁbroblast
growth factor 15 (FGF15) in the intestine of PKCb/ mice.
This study uncovered an interplay between the ileum
PKCb/FGF15/FGF receptor 4 (FGFR4)/extracellular signal
regulated kinase (ERK) axis and the hepatic PKCb/proto-
oncogene serine/threonine-protein kinase (Raf-1)/mitogen-
activated protein (MAP) kinase kinase (MEK)/ERK axis to
modulate hepatic cholesterol and bile acid homeostasis viaCellular and Molecular Gastroenterology and Hepatology 2015;1:350–3lithogenic diet. In PKCb/ mice, this intestine to liver
signaling crosstalk is impaired to exacerbate the lithogenic
diet-induced cholesterol gallstone formation.
This study has added to our increasing appreciation of
the critical role of the gut-to-liver axis in gastrointestinal
diseases, diabetes, and obesity. The gut microbiota are
involved in the deconjugation of conjugated bile acids for
subsequent dehydroxylation of cholic acid and chenodeox-
ycholic acid (primary bile acids) to deoxycholic acid and
lithocholic acid (secondary bile acids), respectively. The
secondary bile acids have antibacteria activity that controls
bacteria overgrowth and inﬂammation in the intestine. It is
somewhat surprising that CYP7A1 expression is reduced in
PKCb/ mice. Previous studies showed that bile acids
activated classic PKCa and novel PKCd in hepatocytes to
activate cJun and (ERK1/2), which inhibited bile acid syn-
thesis.2–4 It is possible that different PKC isoforms
expressed in hepatocytes may have different effects on bile
acid synthesis.
It is also quite intriguing that the lithogenic diet
induced PKCb in wild-type mice, but also induced FGF15
expression in both wild-type and PKCb/ mice. This is in
contrast to the induction of FGF15 by bile acid–activated
farnesoid X receptor in the intestine. It has been reported
that intestine-produced FGF15 may be secreted to the
portal circulation to the hepatocytes to activate FGFR4/b-
Klotho/cJun and ERK1/2 signaling, which inhibits CYP7A1
gene transcription.
Further study is needed to resolve the paradoxical effect
of bile acid–induced PKCb signaling in inhibiting FGF15
production in the intestine and to understand the underlying
molecular mechanism. As suggested by these investigators,
elucidating the impact and the underlying mechanism of
PKCb in diet-induced gallstone formation may identify ther-
apeutic targets for treating this common gastrointestinal
disease.
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